The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sester, D. P.
Right arrow Articles by Stacey, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sester, D. P.
Right arrow Articles by Stacey, K. J.
The Journal of Immunology, 2000, 165: 4165-4173.
Copyright © 2000 by The American Association of Immunologists

Phosphorothioate Backbone Modification Modulates Macrophage Activation by CpG DNA1

David P. Sester, Shalin Naik, Shannon J. Beasley, David A. Hume and Katryn J. Stacey2

Institute for Molecular Bioscience and Departments of Microbiology and Biochemistry, University of Queensland, Brisbane, Australia

Macrophages respond to unmethylated CpG motifs present in nonmammalian DNA. Stabilized phosphorothioate-modified oligodeoxynucleotides (PS-ODN) containing CpG motifs form the basis of immunotherapeutic agents. In this study, we show that PS-ODN do not perfectly mimic native DNA in activation of macrophages. CpG-containing PS-ODN were active at 10- to 100-fold lower concentrations than corresponding phosphodiester ODN in maintenance of cell viability in the absence of CSF-1, in induction of NO production, and in activation of the IL-12 promoter. These enhancing effects are attributable to both increased stability and rate of uptake of the PS-ODN. By contrast, PS-ODN were almost inactive in down-modulation of the CSF-1R from primary macrophages and activation of the HIV-1 LTR. Delayed or poor activation of signaling components may contribute to this, as PS-ODN were slower and less effective at inducing phosphorylation of the extracellular signal-related kinases 1 and 2. In addition, at high concentrations, non-CpG PS-ODN specifically inhibited responses to CpG DNA, whereas nonstimulatory phosphodiester ODN had no such effect. Although nonstimulatory PS-ODN caused some inhibition of ODN uptake, this did not adequately explain the levels of inhibition of activity. The results demonstrate that the phosphorothioate backbone has both enhancing and inhibitory effects on macrophage responses to CpG DNA.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
R. B. Anderson, G. J. Cianciolo, M. N. Kennedy, and S. V. Pizzo
{alpha}2-Macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism
J. Leukoc. Biol., February 1, 2008; 83(2): 381 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Wang, G. Roderiquez, T. Jones, P. McPhie, and M. A. Norcross
Control of In Vitro Immune Responses by Regulatory Oligodeoxynucleotides through Inhibition of pIII Promoter Directed Expression of MHC Class II Transactivator in Human Primary Monocytes
J. Immunol., July 1, 2007; 179(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kindrachuk, J. E. Potter, R. Brownlie, A. D. Ficzycz, P. J. Griebel, N. Mookherjee, G. K. Mutwiri, L. A. Babiuk, and S. Napper
Nucleic Acids Exert a Sequence-independent Cooperative Effect on Sequence-dependent Activation of Toll-like Receptor 9
J. Biol. Chem., May 11, 2007; 282(19): 13944 - 13953.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
S. Levesque, G. Martinez, and J. M. Fairbrother
Improvement of Adjuvant Systems to Obtain a Cost-Effective Production of High Levels of Specific IgY
Poult. Sci., April 1, 2007; 86(4): 630 - 635.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Jozefowski, T. H. Sulahian, M. Arredouani, and L. Kobzik
Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides
J. Leukoc. Biol., October 1, 2006; 80(4): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. H. Harris, N. M. Cooney, J. M. Mansfield, and D. M. Paulnock
Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA.
Infect. Immun., August 1, 2006; 74(8): 4530 - 4537.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kawakami, Y. Ito, P. Charoensit, F. Yamashita, and M. Hashida
Evaluation of Proinflammatory Cytokine Production Induced by Linear and Branched Polyethylenimine/Plasmid DNA Complexes in Mice
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1382 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Roberts, J. A. Dunn, T. D. Terry, M. P. Jennings, D. A. Hume, M. J. Sweet, and K. J. Stacey
Differences in Macrophage Activation by Bacterial DNA and CpG-Containing Oligonucleotides
J. Immunol., September 15, 2005; 175(6): 3569 - 3576.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. F. Ashman, J. A. Goeken, J. Drahos, and P. Lenert
Sequence requirements for oligodeoxyribonucleotide inhibitory activity
Int. Immunol., April 1, 2005; 17(4): 411 - 420.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Roberts, M. J. Sweet, D. A. Hume, and K. J. Stacey
Cutting Edge: Species-Specific TLR9-Mediated Recognition of CpG and Non-CpG Phosphorothioate-Modified Oligonucleotides
J. Immunol., January 15, 2005; 174(2): 605 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Lundberg, P. Welander, X. Han, and E. Cantin
Herpes Simplex Virus Type 1 DNA Is Immunostimulatory In Vitro and In Vivo
J. Virol., October 15, 2003; 77(20): 11158 - 11169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Blackwell and A. M. Krieg
CpG-A-Induced Monocyte IFN-{gamma}-Inducible Protein-10 Production Is Regulated by Plasmacytoid Dendritic Cell-Derived IFN-{alpha}
J. Immunol., April 15, 2003; 170(8): 4061 - 4068.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Stacey, G. R. Young, F. Clark, D. P. Sester, T. L. Roberts, S. Naik, M. J. Sweet, and D. A. Hume
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
J. Immunol., April 1, 2003; 170(7): 3614 - 3620.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F.-G. Zhu, C. F. Reich, and D. S. Pisetsky
Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides
J. Leukoc. Biol., December 1, 2002; 72(6): 1154 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. K. Choudhury, J. S. Wild, R. Alam, D. M. Klinman, I. Boldogh, N. Dharajiya, W. J. Mileski, and S. Sur
In Vivo Role of p38 Mitogen-Activated Protein Kinase in Mediating the Anti-inflammatory Effects of CpG Oligodeoxynucleotide in Murine Asthma
J. Immunol., November 15, 2002; 169(10): 5955 - 5961.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-K. Yi, J.-G. Yoon, S.-J. Yeo, S.-C. Hong, B. K. English, and A. M. Krieg
Role of Mitogen-Activated Protein Kinases in CpG DNA-Mediated IL-10 and IL-12 Production: Central Role of Extracellular Signal-Regulated Kinase in the Negative Feedback Loop of the CpG DNA-Mediated Th1 Response
J. Immunol., May 1, 2002; 168(9): 4711 - 4720.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F.-G. Zhu, C. F. Reich, and D. S. Pisetsky
Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides
J. Leukoc. Biol., April 1, 2002; 71(4): 686 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T.-H. Chuang, J. Lee, L. Kline, J. C. Mathison, and R. J. Ulevitch
Toll-like receptor 9 mediates CpG-DNA signaling
J. Leukoc. Biol., March 1, 2002; 71(3): 538 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. H. Baek, S. J. Ha, and Y. C. Sung
A Novel Function of Phosphorothioate Oligodeoxynucleotides as Chemoattractants for Primary Macrophages
J. Immunol., September 1, 2001; 167(5): 2847 - 2854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.